CITIGROUP INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2021$4,000
-76.5%
1,283
-77.9%
0.00%
Q4 2020$17,000
+88.9%
5,802
+33.8%
0.00%
Q3 2020$9,000
-25.0%
4,337
+64.0%
0.00%
Q2 2020$12,000
-77.8%
2,645
-59.6%
0.00%
Q1 2020$54,000
-26.0%
6,554
+64.3%
0.00%
Q4 2019$73,000
+160.7%
3,988
+57.8%
0.00%
Q3 2019$28,000
-48.1%
2,527
-52.9%
0.00%
Q2 2019$54,000
+63.6%
5,366
-3.3%
0.00%
Q1 2019$33,0000.0%5,550
+20.0%
0.00%
Q4 2018$33,000
-2.9%
4,626
-4.5%
0.00%
Q3 2018$34,000
+30.8%
4,845
+110.1%
0.00%
Q1 2018$26,000
+333.3%
2,306
+229.4%
0.00%
Q4 2017$6,000
+500.0%
700
+669.2%
0.00%
Q2 2017$1,00091
+1720.0%
0.00%
Q1 2016$0
-100.0%
5
-93.2%
0.00%
Q2 2015$1,000740.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 850,129$2,423,0000.65%
Newtyn Management, LLC 700,000$1,995,0000.46%
Portolan Capital Management 1,293,376$3,686,0000.34%
Rubric Capital Management LP 1,076,587$3,068,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 99,046$282,0000.04%
Alyeska Investment Group, L.P. 736,821$2,100,0000.03%
STEPHENS INC /AR/ 510,569$1,455,0000.03%
Clear Harbor Asset Management, LLC 46,682$133,0000.02%
WYNNEFIELD CAPITAL INC 13,000$37,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 451,301$1,286,0000.01%
View complete list of RECRO PHARMA INC shareholders